as aVenture Partner and Finny Kuruvilla M

5 /PRNewswire/ Clarus Ventures, LLC ("Clarus Ventures"), a leading life sciences venturecapital firm, announced today the hiring of Edward Scolnick, M.D., as aVenture Partner and Finny Kuruvilla, M.D., Ph.D., as a Principal in the Firm'sCambridge, Mass office."Both Drs. Scolnick and Kuruvilla have clinical backgrounds rooted in theirdeep understanding of science and technology," said Nick Galakatos, Ph.D., aManaging Director for Clarus."Their addition to our Clarus team will furtherenhance our ability to identify and build companies with highly innovativeproducts that address significant unmet medical needs." Dr. Edward Scolnick joins Clarus Ventures as a Venture Partner, exclusive tothe firm, from the Broad Institute of MIT and Harvard where he is Director ofthe Stanley Center for Psychiatric Research.In this capacity he oversees theleading effort in the world to identify the genetic basis of schizophrenia andbipolar illness and to find innovative medicines to treat these illnesses Prior to the Broad, Dr. Scolnick was President of the Merck Research Labswhere over a 17-year period he oversaw the discovery, development and approvalof over 16 new medicines across several disease indications.He joined Merckfrom the National Institutes of Health where for 15 years seminal discoverieswere made on the nature of cancer-causing genes in humans.Dr. Scolnick received his bachelor's degree in biochemical sciences fromHarvard University and his M.D. degree from Harvard Medical School.Hecompleted his residency in Internal Medicine at the Massachusetts GeneralHospital.He was a Senior Staff Fellow at both the National Heart Instituteand National Cancer Institute.He was later Head of the Genetics Section inthe Viral Leukemia & Lymphoma Branch, Chief of the Laboratory of Tumor VirusGenetics and Head of the Molecular Virology Section, LTVG, at the NationalCancer Institute."Few physician scientists are as accomplished and have made such a fundamentalimpact in the pharmaceutical industry as Ed Scolnick," said Dr Galakatos. Kuruvilla'sresearch focused on the elucidation of the mechanism of action of rapamycin In addition to his scientific achievements, Dr.

Kuruvilla has been apracticing physician and cared for adult and pediatric patients suffering froma variety of hematologic, oncologic and autoimmune disorders at the Brigham &Women's Hospital, Children's Hospital Boston, the Dana-Farber CancerInstitute, the Beth Israel Deaconess Medical Center and the MassachusettsGeneral Hospital.Dr. Kuruvilla received his bachelor's degree in chemistry from Caltech, hismaster's degree in electrical engineering and computer science from MIT, hisPh.D. in chemistry and chemical biology from Harvard University and his M.D.from Harvard Medical School. He completed his residency at the Brigham &Women's Hospital and his fellowship in transfusion medicine at Harvard MedicalSchool."With his very strong scientific and clinical background, Finny willstrengthen our team in translational medicine and help identify the nextgeneration of innovative companies for Clarus to invest in," said Dr.Galakatos. About Clarus VenturesClarus Ventures is a life sciences venture capital firm founded by a team ofaccomplished investment professionals with extensive and complementaryindustry backgrounds which have enabled them to establish a long history ofsuccess in creating value. Their deep relationships with world thought leadersand decision makers allow this team to identify unique investmentopportunities and shepherd them to maturity.

Please understand my key fundamental belief: The thought of trading Derrick Rose in his second season in the NBA is both ludicrous and laughable.But not as laughable as leaving his development in the hands of Vinny Del Negro.As long as the Bulls management is going to continue wasting this year, and the development of future cornerstones like Joakim Noah and Rose, the team might as well at least explore what they could get in return for a top-tier player like Rose.In case you missed it, the Bulls are a waste of television minutes right now, and sponsors should ask for their money back.In a wide-open Eastern Conference where nothing is settled except ESPN's love for Boston and LeBron, the Bulls have taken a backseat to mediocrity and are now the second-tier team in their own building.Quietly, Noah has turned into one heck of a rebounder, and to his credit, has put in a lot of long, hard hours trying to develop an offensive game. Wisair Extends Wireless USB Offerings With New Display Adapter Set SolutionThat Wirelessly Transfers PC Content to TVs, Monitors and ProjectorsProduct, based on WSR601 single chip, to be available through Cables Unlimitedin the U.S., will be demonstrated at CESCAMPBELL, Calif., Jan. 5 /PRNewswire/ Wisair, a leading provider ofsingle-chip based Wireless USB solutions, today announced the availability ofa Wireless USB Display Adapter Set solution that wirelessly transfers PCcontent to TVs, monitors and projectors. Featuring Wisair's WSR601 WirelessUSB single chip, the adapter set allows users to wirelessly extend theirvisual workspace from a PC to a large screen or projector for the purpose ofdisplaying movies, Internet content, pictures and presentations. The WirelessDisplay Adapter Set will be available this quarter by Cables Unlimited in theU.S., and through European retailers.The Wireless USB Display Adapter Set is delivered with a pre-paired PC adapterto provide a complete, easy-to-install product.The Display Adapter Setfeatures VGA and HDMI connectivity options, capable of transferring HD movies,supports up to 1400x1050 screen resolution, and is a fully-standard USB-IFcertified solution.

The set is expected to be available in the US at an MSRPof $129USD."The Wireless USB Display Adapter Set is the most innovative, low cost andhigh performance solution in the market," noted David Yaish, Wisair presidentand CEO." Wisair is continuing to offer high performance Wireless USBsolutions that enable our customers to introduce to the market significantlylower cost products relative to any other products in the market. We are ableto do so due to our low cost single CMOS chip and our innovation. Additionalsolutions that will enable more products are expected throughout the comingyear."Ben Hunter, Cables Unlimited CEO, noted "Wirelessly projecting content from aPC across the room to a large flat TV is an attractive proposition for bothliving room and office context.We selected to cooperate with Wisair as itoffers the best price to performance Wireless USB combination. All these solutions will be demonstrated at the ConsumerElectronics Show (CES) in Las Vegas in Wisair's meeting room (LVCC, South Hall4, 35162MP). The Wireless USB Display Adapter Set will also be demonstratedat the Cables Unlimited booth, LVCC, South Hall 1, 22044.About WisairWisair is a fabless semiconductor company providing Ultra Wideband (UWB) andCertified Wireless USB solutions based on its CMOS single chip.